The Discounted Cash Flow (DCF) valuation of Knight Therapeutics Inc (GUD.TO) is 2.73 CAD. With the latest stock price at 6.04 CAD, the upside of Knight Therapeutics Inc based on DCF is -54.9%.
Based on the latest price of 6.04 CAD and our DCF valuation, Knight Therapeutics Inc (GUD.TO) is a sell. selling GUD.TO stocks now will result in a potential gain of 54.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.7% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 1.55 - 22.67 | 2.73 |
| Upside | -74.4% - 275.3% | -54.9% |